Abstract
Mapping the key signaling molecules in biochemical pathways will be central to future drug discovery efforts.
References
Koman, A. et al. J. Bacteriol. 138, 739–747 (1979).
Eckhart, W. et al. Cell 18, 925–933 ( 1979).
Hunter, T. & Sefton, B.M. Proc. Natl. Acad. Sci. USA 77, 1311–1315 (1980).
Ushiro, H. & Cohen, S. J. Biol. Chem. 255, 8363–8365 (1980).
Smith, M.R. et al. Nature 320, 540–543 ( 1986).
Cook, S.J. & McCormick, F. Science 262, 1069–1072 (1993).
Wu, J. et al. Science 262, 1065–1069 ( 1993).
Kerr, J.F.R. et al. Br. J. Cancer 26, 239–257 (1972).
Wilson, K.F. & Cerione, R.A. Biol. Chem. 381, 357–365 (2000).
Schlador, M.L. et al. J. Biol. Chem. 275, 23295– 23302 (2000).
Roisin, M.P. et al. Parasitol. Res. 86, 588–598 (2000).
Rights and permissions
About this article
Cite this article
Signal transduction as a drug-discovery platform. Nat Biotechnol 18 (Suppl 10), IT37–IT39 (2000). https://doi.org/10.1038/80076
Issue Date:
DOI: https://doi.org/10.1038/80076
- Springer Nature America, Inc.
This article is cited by
-
Dactolisib (NVP-BEZ235) toxicity in murine brain tumour models
BMC Cancer (2016)